Article ID Journal Published Year Pages File Type
7864184 Journal of Controlled Release 2014 9 Pages PDF
Abstract
cRGD-functionalized and NIR-responsive AuNR/PEG-PCL hybrid nanoparticles mediate targeted delivery as well as remotely controlled release of doxorubicin into human glioblastoma xenografts in mice, leading to complete inhibition of tumor growth with little adverse effects and 100% mice survival over an experimental period of 48 days.189
Keywords
Related Topics
Physical Sciences and Engineering Materials Science Biomaterials
Preview
cRGD-directed, NIR-responsive and robust AuNR/PEG-PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo
Authors
, , , , , , ,